Caffeine Augments Anesthesia Neurotoxicity in the Fetal Macaque Brain

Area of Science:

• Neuroscience
• Neonatal Research
• Pharmacology

Background:

• Caffeine is a widely used respiratory stimulant in premature infants.
• Anesthetic drugs, like isoflurane, can cause neurotoxicity and cell death in developing brains.
• The safety of caffeine in conjunction with anesthesia in neonates is not fully understood.

Purpose of the Study:

• To investigate the effect of caffeine on anesthesia-induced neurotoxicity in developing nonhuman primate brains.
• To determine if caffeine mitigates or exacerbates the effects of isoflurane on neuronal and oligodendrocyte apoptosis.

Main Methods:

• Fetal macaques, at a developmental stage comparable to premature human infants, were exposed in utero to control, isoflurane, or isoflurane + caffeine.
• Apoptosis (programmed cell death) in neurons and oligodendrocytes was quantified in brain tissue.
• Blood caffeine levels were correlated with neuroapoptosis.

Main Results:

• Isoflurane exposure significantly increased apoptosis in both neurons (3.3-fold) and oligodendrocytes (3.4-fold) compared to controls.
• Combined isoflurane and caffeine exposure resulted in an 8.0-fold increase in neuronal apoptosis compared to controls.
• Caffeine did not increase oligodendrocyte apoptosis but significantly augmented isoflurane-induced neuronal death, particularly in the basal ganglia and cerebellum.
• Higher therapeutic caffeine levels correlated with increased neuroapoptosis.

Conclusions:

• Caffeine significantly augments the neurotoxic effects of isoflurane in the developing primate brain.
• This finding challenges the long-held assumption that caffeine is universally safe for premature infants, especially when used with anesthetics.
• Further research is needed to understand the implications for neonatal care and anesthetic protocols.